This Government Contract opportunity from Department Of Veterans Affairs was posted on June 10, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Notice Of Intent to Sole Source
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Department of Veterans Affairs, through its 247-NETWORK Contract Office 7 based in Augusta, Georgia, intends to sole source a contract for the procurement of FibroScan devices used by the RHJVAMC Gastroenterology Section. These devices employ proprietary Vibration Controlled Transient Elastography (VCTE) and Controlled Attenuation Parameter (CAP) technologies to noninvasively measure liver stiffness and fat content, which are critical for diagnosing and managing Non-Alcoholic Fatty Liver Disease (NAFLD). The use of these FibroScan devices significantly improves efficiency by reducing time, costs, patient discomfort, and minimizing operator error in liver health assessments. The solicitation, identified as 36C24726Q0586, is a special notice with a set-aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSB), emphasizing the VA’s commitment to supporting these businesses. The contract performance location is in Charleston, South Carolina, with a response deadline set for June 15, 2026. For inquiries, Monica A. Reed serves as the primary point of contact. This sole source action ensures continued access to the advanced diagnostic technology required for effective liver disease management within the VA healthcare system.
General Info
Agency
NAICS
Place of Performance
Charleston, SC, 29401, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The RHJVAMC Gastroenterology Section currently uses FibroScan devices to noninvasively collect measurements on liver stiffness and fat content. These results are crucial to identifying and managing Non-Alcoholic Fatty Liver Disease (NAFLD). The proprietary Vibration Controlled Transient Elastography (VCTE), and Controlled Attenuation Parameter (CAP), technologies of the FibroScan immensely reduce time, costs, patient discomfort, and operator error in measuring liver disease metrics.
